U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06862960) titled 'Ozanimod in Patients with Alzheimer's Disease' on March 05.
Brief Summary: The purpose of this study is to investigate the benefits of ozanimod in patients with moderate Alzheimer's disease.
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Alzheimer Disease
Intervention:
DRUG: Ozanimod
A sphingosine-1-phosphate receptor regulator
DRUG: Conventional medication
Conventional medications for moderate AD
Recruitment Status: NOT_YET_RECRUITING
Sponsor: ChenXiaoChun
Information provided by (Responsible Party): ChenXiaoChun, Fujian Medical University Union Hospital
Disclaimer: Curated by HT Syndication....